InMed Pharmaceuticals Inc
For the period ended Jun 30, 2024. Filed Sep 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 30, 2024
INM$15.56+17.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| June 30, | June 30, | |
|---|---|---|
| 2024 | 2023 | |
| $ | $ | |
| ASSETS | ||
| Current | ||
| Cash and cash equivalents | 6,571,610 | 8,912,517 |
| Short-term investments | 43,064 | 44,422 |
| Accounts receivable (less provision for credit losses of $nil and $66,775 in June 30, 2024 and 2023, respectively) | 352,838 | 260,399 |
| Inventories, net | 1,244,324 | 1,616,356 |
| Prepaids and other current assets | 477,749 | 498,033 |
| Total current assets | 8,689,585 | 11,331,727 |
| Non-Current | ||
| Property, equipment and ROU assets, net | 1,249,999 | 723,426 |
| Intangible assets, net | 1,783,198 | 1,946,279 |
| Other assets | 100,000 | 104,908 |
| Total Assets | 11,822,782 | 14,106,340 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current | ||
| Accounts payable and accrued liabilities | 1,654,011 | 1,608,735 |
| Current portion of lease obligations | 317,797 | 375,713 |
| Deferred rent | - | 16,171 |
| Total current liabilities | 1,971,808 | 2,000,619 |
| Non-current | ||
| Lease obligations, net of current portion | 644,865 | 15,994 |
| Total Liabilities | 2,616,673 | 2,016,613 |
| Commitments and Contingencies (Note 12) | ||
| Shareholders’ Equity | ||
| Common shares, no par value, unlimited authorized shares: 8,918,956 and 3,328,191 as of June 30, 2024 and 2023, respectively, issued and outstanding | 82,784,400 | 77,620,252 |
| Additional paid-in capital | 35,368,899 | 35,741,115 |
| Accumulated deficit | (109,075,759) | (101,400,209) |
| Accumulated other comprehensive income | 128,569 | 128,569 |
| Total Shareholders’ Equity | 9,206,109 | 12,089,727 |
| Total Liabilities and Shareholders’ Equity | 11,822,782 | 14,106,340 |
| Related Party Transactions (Note 13) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.